Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis

0.05, group 4 versus groups 1 and 2, group 3 versus group 2). Conclusions: In patients with recent-onset active RA, drug-free remission was achieved in up to 18% of patients. DAS-driven treatment maintained clinical and functional improvement, independent of the treatment strategy. Joint damage progression remained significantly lower after initial combination therapy compared with initial monotherap

Can we prevent rapid radiological progression in patients with early rheumatoid arthritis?

Pathophysiology and treatment of rheumatic disease

Health-related quality of life and functional ability in patients with early arthritis during remission steered treatment: results of the IMPROVED study

Pathophysiology and treatment of rheumatic disease

FIVE YEAR OUTCOMES OF REMISSION STEERED TREATMENT INCLUDING DRUG TAPERING STRATEGIES IN EARLY ARTHRITIS PATIENTS

Pathophysiology and treatment of rheumatic disease

A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study

Pathophysiology and treatment of rheumatic disease

Clinical and radiological outcomes of 5-year drug-free remission-steered treatment in patients with early arthritis: IMPROVED study

Pathophysiology and treatment of rheumatic disease